indobufen has been researched along with Coronary Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 6 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collet, JP | 1 |
| Bassi, A; Borghi, B; Gargioni, G; Grazia, M; Pignotti, E | 1 |
| Kochmański, M; Rdzanek, H; Zochowski, RJ | 1 |
| Buckley, MM; Fitton, A; Wiseman, LR | 1 |
| Bernini, W; De Caterina, R; Efthymiopoulos, C; Giannessi, D; Lazzerini, G; Sicari, R; Strolin-Benedetti, M; Yan, A | 1 |
| Peregrin, J; Pirk, J; Rohn, V | 1 |
| Braconaro, F; Citella, C; Colombo, L; Craveri, A; Lanfredini, M | 1 |
2 review(s) available for indobufen and Coronary Disease
| Article | Year |
|---|---|
[Management of aspirin discontinuation in stable coronary heart disease prior to elective surgery].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Disease; Cyclooxygenase Inhibitors; Drug Administration Schedule; Drug Monitoring; Elective Surgical Procedures; Flurbiprofen; Humans; Isoindoles; Metabolic Clearance Rate; Phenylbutyrates; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Preoperative Care; Risk Factors; Time Factors | 1999 |
Indobufen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cerebral, peripheral and coronary vascular disease.
Topics: Cerebrovascular Disorders; Coronary Disease; Humans; Isoindoles; Phenylbutyrates; Platelet Aggregation Inhibitors; Vascular Diseases | 1992 |
3 trial(s) available for indobufen and Coronary Disease
| Article | Year |
|---|---|
The d-enantiomer form of indobufen totally accounts for the anti-cyclooxygenase and antiplatelet activity ex vivo and for the increase in bleeding time by indobufen in man.
Topics: Aged; Bleeding Time; Coronary Disease; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Prospective Studies; Stereoisomerism | 1992 |
The effect of ibustrin on early aortocoronary bypass patency.
Topics: Angiography, Digital Subtraction; Aspirin; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Graft Occlusion, Vascular; Humans; Isoindoles; Phenylbutyrates; Platelet Aggregation Inhibitors; Prospective Studies | 1990 |
Long-term antiplatelet activity and safety of indobufen in patients with cardiovascular disease. Italian Multicenter Study Group.
Topics: Adult; Aged; Arterial Occlusive Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Drug Tolerance; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Isoindoles; Male; Middle Aged; Patient Compliance; Phenylbutyrates; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Time Factors | 1985 |
3 other study(ies) available for indobufen and Coronary Disease
| Article | Year |
|---|---|
Anaesthesia and autologous transfusion.
Topics: Adult; Aged; Aged, 80 and over; Anesthesiology; Anticoagulants; Blood Transfusion, Autologous; Coronary Disease; Female; Hemodilution; Hemoglobins; Heparin; Hip Prosthesis; Humans; Intraoperative Complications; Isoindoles; Knee Prosthesis; Longitudinal Studies; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Postoperative Complications; Sex Factors; Thromboembolism | 1995 |
[Effect of treatment with indobufen on blood viscosity indices and exercise tolerance in patients with coronary disease].
Topics: Adult; Aged; Blood Viscosity; Coronary Disease; Electrocardiography; Exercise; Female; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors | 1993 |
[Evaluation of morning platelet aggregation in patients with ischemic cardiopathy after evening administration of indobufen].
Topics: Aged; Coronary Disease; Female; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation; Platelet Aggregation Inhibitors; Time Factors | 1988 |